CANCER: New gene assay predicts colon cancer recurrence CANCER: Standard of care for advanced biliary tract cancer established Chemo should be standard approach for metastatic colorectal cancer 93% of patients had no future complications with chemo CANCER: North American chemo standard tops European standard for pancreatic cancer Gemcitabine offers fewer side-effects than 5-FU/FA, with same survival CANCER: Drug may reduce distant metastases in rectal cancer Mutant cows make anti-carcinogenic milk CANCER: Anal cancer gold standard remains best approach Tykerb: new drug for advanced breast cancer L GlaxoSmithKline is introducing Tykerb, a dual kinase inhibitor that inhibits breast cancer cell growth. Urine tests show promise as cancer biomarkers . Family doctors likely to see expanded CA role Head of Novartis Oncology gives an insider view on drug development; warns that as therapies help cancer patients live longer, long-term care will fall to family physicians First Previous 71 72 73 74 Next Last
